Monday, October 13, 2014

Another Must Read Comment from Reader!!


As stated, the AAO/OMIC appear to believe that the intent of USP 797 is to prevent infection. This is incorrect
. Infection control is related but separate from quality control, and more specifically contamination control,
 which at the broad and granular impact safety AND effectiveness well beyond infection risk, for example, 
hypersensitivity reactions to antibody dimers/trimers or other contaminating particulate, or physical-chemical-biologic
 tissue incompatibilities. The informed consent as described could simply advise patients 
of the off-label indication and not the risks associated with off-label preparation and off-label route of administration,
 resulting in federal quality attribute destruction. on Verifying the Source of Compounded Bevacizumab 

No comments: